Santen Pharmaceutical Co (MEX:4536N) Cyclically Adjusted FCF per Share: MXN12.99 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:4536N Santen Pharmaceutical Co Ltd MEX:4536N
80 GF Score
Price MXN339.23
GF Value MXN299.21
View Full Analysis

What is Santen Pharmaceutical Co Cyclically Adjusted FCF per Share?

Santen Pharmaceutical Co MEX:4536N 80 Cyclically Adjusted FCF per Share is MXN12.99 as of Jun. 2026. GuruFocus rates MEX:4536N with a GF Score™ of 80/100 and a GF Value™ of MXN299.21.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Santen Pharmaceutical Co's adjusted free cash flow per share for the three months ended in Jun. 2026 was MXN1.449. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN12.99 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Santen Pharmaceutical Co's average Cyclically Adjusted FCF Growth Rate was 14.70% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 31.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Santen Pharmaceutical Co was 31.00% per year. The lowest was -1.60% per year. And the median was 4.10% per year.

As of today (2026-08-12), Santen Pharmaceutical Co's current stock price is MXN339.23. Santen Pharmaceutical Co's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was MXN12.99. Santen Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is 26.11.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Santen Pharmaceutical Co was 76.54. The lowest was 20.13. And the median was 42.25.


Santen Pharmaceutical Co  (MEX:4536N) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Santen Pharmaceutical Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=339.23/12.99
=26.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Santen Pharmaceutical Co was 76.54. The lowest was 20.13. And the median was 42.25.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Santen Pharmaceutical Co Cyclically Adjusted FCF per Share Related Terms


Santen Pharmaceutical Co Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Santen Pharmaceutical Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Santen Pharmaceutical Co Cyclically Adjusted FCF per Share Chart

Santen Pharmaceutical Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.68 9.94 9.85 0.00 14.15

Santen Pharmaceutical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.61 14.00 14.42 14.15 12.99

MEX:4536N vs LLY, JNJ, ABBV: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - General subindustry, Santen Pharmaceutical Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Santen Pharmaceutical Co Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Santen Pharmaceutical Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Santen Pharmaceutical Co's Cyclically Adjusted Price-to-FCF falls into.


MEX:4536N
80GF Score
Santen Pharmaceutical Co Ltd MEX:4536N
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Santen Pharmaceutical Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Santen Pharmaceutical Co's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.449/113.6000*113.6000
=1.449

Current CPI (Jun. 2026) = 113.6000.

Santen Pharmaceutical Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 3.837 98.000 4.448
201612 1.498 98.400 1.729
201703 3.175 98.100 3.677
201706 1.556 98.500 1.795
201709 5.570 98.800 6.404
201712 2.024 99.400 2.313
201803 4.367 99.200 5.001
201806 -2.089 99.200 -2.392
201809 7.526 99.900 8.558
201812 1.039 99.700 1.184
201903 3.664 99.700 4.175
201906 1.285 99.800 1.463
201909 7.461 100.100 8.467
201912 0.538 100.500 0.608
202003 5.612 100.300 6.356
202006 -0.487 99.900 -0.554
202009 3.297 99.900 3.749
202012 -1.196 99.300 -1.368
202103 5.683 99.900 6.462
202106 -0.994 99.500 -1.135
202109 6.895 100.100 7.825
202112 -0.863 100.100 -0.979
202203 -0.198 101.100 -0.222
202206 -1.448 101.800 -1.616
202209 2.305 103.100 2.540
202212 2.023 104.100 2.208
202303 1.693 104.400 1.842
202306 -0.127 105.200 -0.137
202309 7.472 106.200 7.993
202312 9.993 106.800 10.629
202403 2.839 107.200 3.008
202406 3.591 108.200 3.770
202409 4.921 108.900 5.133
202412 3.817 110.700 3.917
202503 0.000 111.100 0.000
202506 2.247 111.700 2.285
202509 -0.641 112.000 -0.650
202512 2.331 113.000 2.343
202603 6.378 112.700 6.429
202606 1.449 113.600 1.449

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of MXN12.99 mean?
Santen Pharmaceutical Co (MEX:4536N) has a Cyclically Adjusted FCF per Share of MXN12.99 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Santen Pharmaceutical Co and its competitors.
Is Santen Pharmaceutical Co's Cyclically Adjusted FCF per Share too high?
Santen Pharmaceutical Co's current Cyclically Adjusted FCF per Share is MXN12.99. Overall, Santen Pharmaceutical Co has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Santen Pharmaceutical Co's Cyclically Adjusted FCF per Share compare to LLY and JNJ?
Santen Pharmaceutical Co's Cyclically Adjusted FCF per Share of MXN12.99 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Santen Pharmaceutical Co and its competitors. Santen Pharmaceutical Co's current Cyclically Adjusted FCF per Share is MXN12.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Santen Pharmaceutical Co stock overvalued right now?
Santen Pharmaceutical Co (MEX:4536N) has a current Cyclically Adjusted FCF per Share of MXN12.99. The stock's GF Value™ is MXN299.21, compared to a current price of MXN339.23 — trading 13.4% above its estimated fair value. The current Cyclically Adjusted FCF per Share is MXN12.99. Santen Pharmaceutical Co's overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Santen Pharmaceutical Co (MEX:4536N), the current Cyclically Adjusted FCF per Share is MXN12.99 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Santen Pharmaceutical Co (MEX:4536N) Overvalued in 2026?

Based on GuruFocus' analysis, Santen Pharmaceutical Co stock appears to be overvalued. The current stock price of MXN339.23 is trading 13.4% above its estimated GF Value™ of MXN299.21.

Key valuation signals for MEX:4536N:

  • Cyclically Adjusted FCF per Share: MXN12.99
  • GF Value™: MXN299.21 vs. price of MXN339.23 (13.4% above fair value)
  • GF Score™: 80/100

No single metric tells the full story. See the MEX:4536N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Santen Pharmaceutical Co Business Description

Other Exchanges SNPHY:USA4536:Japan
Address 4-20 Ofukacho, Grand Front Osaka Tower A, Kita-ku, Osaka Prefecture, Osaka, JPN, 530-8552
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. The company provides a wide range of prescription and over-the-counter eye care products, including treatments for glaucoma, dry eye, and allergies. It also develops surgical and diagnostic devices related to eye care.
80GF Score

Get the complete analysis for MEX:4536N

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN339.23
Price
MXN299.21
GF Value